Pharmamed Director Sanjin Kotlica: A Market for Over 200 Pharmaceutical Products Opens Up for Us

The entry of Bosnia and Herzegovina's largest pharmaceutical company, Bosnalijek, into Pharmamed's ownership structure is positive news for this company as it opens up a market for over 200 new products, writes the Patria agency.

The director of Pharmamed d.o.o. Travnik, Sanjin Kotlica, states that BiH has something to offer in the pharmaceutical industry on the European and global markets for medicines, herbal medicines, and dietary supplements.

- We are pleased that Bosnalijek has recognized Pharmamed as a partner on the domestic "ground".

Kotlica says that although their products are already present on the European market, as well as the markets of the Middle East and Africa, this will be a significant step forward and open up new opportunities for an assortment of over 200 products, including medicines, medical devices, dietary supplements, and cosmetics, including cosmetics for special purposes.

- We believe that together with Bosnalijek, we will make a stronger push into existing markets. We are confident that cooperation with such a large pharmaceutical company, which has recently recorded constant growth in production and revenue, and is making inroads into the huge Russian market and other foreign markets, will also open up real opportunities for the placement of Pharmamed's products, and greatly facilitate the growth and development of our company – Kotlica emphasizes.